SMN2 and amyotrophic lateral sclerosis: Echaniz-Laguna and Lee [38] concluded that homozygous SMN2 deletion is a risk factor for developing amyotrophic lateral sclerosis (ALS), whereas Corcia [26] suggested that it is a preventive factor against ALS progression in some ethnicities.